1998
DOI: 10.1080/00016489850154801
|View full text |Cite
|
Sign up to set email alerts
|

Caroverine in Tinnitus Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(4 citation statements)
references
References 5 publications
0
4
0
Order By: Relevance
“…Other drugs already studied for treatment of tinnitus are lidocaine,[12] antidepressants,[13] baclofen,[14] caroverine,[15] nimodipine,[16] clonazepam[17] and trimetazidine. [18] The introduction of these drug therapies have increased the success of tinnitus treatment.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Other drugs already studied for treatment of tinnitus are lidocaine,[12] antidepressants,[13] baclofen,[14] caroverine,[15] nimodipine,[16] clonazepam[17] and trimetazidine. [18] The introduction of these drug therapies have increased the success of tinnitus treatment.…”
Section: Discussionmentioning
confidence: 99%
“…However, the systemic use of nonselective glutamate receptor blockers such as caroverine is limited by severe neurological and psychiatric side effects. [15]…”
Section: Discussionmentioning
confidence: 99%
“…A single intravenous injection of caroverine was found to immediately alleviate tinnitus in 63% of patients, with 43% of those who showed improvement continuing to show improvement one week after treatment [ 63 ]. In contrast, a second study using the same design found that caroverine did not demonstrate any significant therapeutic effects [ 64 ]. Memantine is a voltage-dependent antagonist against NMDA receptors that decreases excitotoxicity by reducing calcium influx, which has been approved for treatment of patients with Alzheimer’s disease [ 65 ].…”
Section: Medications For Tinnitusmentioning
confidence: 99%
“…A larger clinical trial is currently underway to analyze the encouraging results from this preliminary study (http://clinicaltrials.gov/ct2/show/ NCT00596531). Treatment with intravenous caroverine, an antagonist of non-NMDA and NMDA receptors, has been analyzed, with contradictory results [50,51]. In a prospective, randomized, double-blind cross-over study using the Tinnitus Handicap Inventory to assess efficacy, 90-day treatment with the non-selective NMDA antagonist memantine was no more effective than placebo [52].…”
Section: Pharmacological Treatment Of Tinnitusmentioning
confidence: 99%